AG142005: β-D-GalNAc-Butyl-Carboxylic Acid Pack Size:50 mg 4-Carboxybutyl 2-acetamido-2-deoxy-β-D-galactopyranoside

4-Carboxybutyl 2-acetamido-2-deoxy-β-D-galactopyranoside

4-Carboxybutyl 2-acetylamino-2-deoxy-β-D-galactopyranoside

The carboxylic acid can be activated to NHS

32 / A β-D-N-acetylgalactosamine (GalNAcβ) ligand equipped with a terminal carboxylic acid through a short butyl spacer

AG142005: β-D-GalNAc-Butyl-Carboxylic Acid Pack Size:50 mg 4-Carboxybutyl 2-acetamido-2-deoxy-β-D-galactopyranosideC13H23NO8 321. 32 A D N acetylgalactosamine (GalNAc) ligand equipped with a terminal carboxylic acid through a short butyl spacer. The carboxylic acid can be activated to NHS, sulfo NHS, or pentafluorophenyl (PFP) esters and reacted with amine functionalized platforms or lysine residues on proteins and peptides to form stable amide bonds. This compound enables the construction of hepatocyte targeted therapeutics and research tools that exploit the